Please provide your email address to receive an email when new articles are posted on . Cipla voluntarily recalled six batches of albuterol sulfate inhalation aerosol 90 mcg after a leak was ...

India’s Cipla Limited (BSE: 500087) announced the launch of Afrezza (insulin human) Inhalation Powder in India.

Employees and security staff work at the reception area of Cipla at its headquarters in Mumbai BENGALURU (Reuters) -Indian drugmaker Cipla said on Friday its U.S. unit was recalling six batches of ...

The Multidisciplinary Committee (MDC) of Experts, that advises the National Pharmaceutical Pricing Authority (NPPA) on pricing related matters, has recommended to close the matter related to special ...

Cipla has launched inhaled insulin powder in India, providing a needle-free alternative for diabetes patients. Approved by ...

A pharmaceutical company has recalled six batches of albuterol sulfate inhalers after a complaint from one patient that the inhaler leaked. Cipla US is voluntarily recalling the 90 mcg inhalers that ...

Indian pharmaceutical company Cipla has announced that its US unit is recalling six batches of albuterol sulfate inhalation aerosol due to a container defect, Reuters reported. The recall was ...

Manufactured by Connecticut-based biopharmaceutical company MannKind Corporation, Afrezza was first launched in the United ...

The Multidisciplinary Committee (MDC) of Experts which advices the National Pharmaceutical Pricing Authority (NPPA) on pricing related matters, has decided to place a complete point-wise examination ...

FALL RIVER, Mass., Aug. 7, 2025 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla" today announced a significant expansion of its manufacturing facility ...

BENGALURU (Reuters) -Indian drugmaker Cipla said on Friday its U.S. unit was recalling six batches of albuterol sulfate inhalation aerosol due to a "container defect". "The company is initiating a ...